109 related articles for article (PubMed ID: 6781)
1. Urinary excretion of probenecid and its metabolites in humans as a function of dose.
Melethil S; Conway WD
J Pharm Sci; 1976 Jun; 65(6):861-5. PubMed ID: 6781
[TBL] [Abstract][Full Text] [Related]
2. Probenecid disposition by parallel Michaelis-Menten and dose-dependent pseudo-first-order processes.
Ho JC; Conway WD; Melethil S
J Pharm Sci; 1986 Jul; 75(7):664-8. PubMed ID: 3761166
[TBL] [Abstract][Full Text] [Related]
3. Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.
Vree TB; Van Ewijk-Beneken Kolmer EW; Wuis EW; Hekster YA; Broekman MM
Pharm World Sci; 1993 Oct; 15(5):197-202. PubMed ID: 8257956
[TBL] [Abstract][Full Text] [Related]
4. Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.
Vree TB; Van Ewijk-Beneken Kolmer EW; Wuis EW; Hekster YA
Pharm Weekbl Sci; 1992 Oct; 14(5):325-31. PubMed ID: 1437517
[TBL] [Abstract][Full Text] [Related]
5. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.
Upton RA; Buskin JN; Williams RL; Holford NH; Riegelman S
J Pharm Sci; 1980 Nov; 69(11):1254-7. PubMed ID: 7452451
[TBL] [Abstract][Full Text] [Related]
6. Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.
Vree TB; Beneken Kolmer EW
Pharm Weekbl Sci; 1992 Jun; 14(3):83-7. PubMed ID: 1630876
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent kinetics of probenecid in rhesus monkeys-intravenous bolus studies.
Chiang CW; Benet LZ
Pharmacology; 1981; 23(6):326-36. PubMed ID: 7312942
[TBL] [Abstract][Full Text] [Related]
8. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
Smith PC; Langendijk PN; Bosso JA; Benet LZ
Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
[TBL] [Abstract][Full Text] [Related]
9. Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.
Vree TB; Van den Biggelaar-Martea M; Van Ewijk-Beneken Kolmer EW; Hekster YA
Pharm World Sci; 1993 Aug; 15(4):165-70. PubMed ID: 8220301
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of probenecid.
Cunningham RF; Israili ZH; Dayton PG
Clin Pharmacokinet; 1981; 6(2):135-51. PubMed ID: 7011657
[TBL] [Abstract][Full Text] [Related]
11. Effects of urinary pH on renal interactions between probenecid and cefsulodin in rabbits.
Dromer F; Contrepois A; Brion N; Klein C; Carbon C
Antimicrob Agents Chemother; 1985 Apr; 27(4):660-2. PubMed ID: 4004198
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the human kidney to the metabolic clearance of drugs.
Vree TB; Hekster YA; Anderson PG
Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449
[TBL] [Abstract][Full Text] [Related]
13. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
[TBL] [Abstract][Full Text] [Related]
14. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolite excretion after oral dosage of bis(2-propylheptyl) phthalate (DPHP) to five male volunteers--characterization of suitable biomarkers for human biomonitoring.
Leng G; Koch HM; Gries W; Schütze A; Langsch A; Brüning T; Otter R
Toxicol Lett; 2014 Dec; 231(2):282-8. PubMed ID: 24973492
[TBL] [Abstract][Full Text] [Related]
16. The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man.
Yü TF; Perel J; Berger L; Roboz J; Israili ZH; Dayton PG
Am J Med; 1977 Nov; 63(5):723-8. PubMed ID: 930947
[TBL] [Abstract][Full Text] [Related]
17. Rapid high-performance liquid chromatographic assay for the simultaneous determination of probenecid and its glucuronide in urine. Irreversible binding of probenecid to serum albumin.
Hansen-Møller J; Schmit U
J Pharm Biomed Anal; 1991; 9(1):65-73. PubMed ID: 2043725
[TBL] [Abstract][Full Text] [Related]
18. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
Cundy KC; Li ZH; Lee WA
Drug Metab Dispos; 1996 Mar; 24(3):315-21. PubMed ID: 8820422
[TBL] [Abstract][Full Text] [Related]
19. The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.
Baber N; Halliday L; Sibeon R; Littler T; Orme ML
Clin Pharmacol Ther; 1978 Sep; 24(3):298-307. PubMed ID: 688724
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent kinetics of probenecid in rhesus monkeys--infusion studies.
Chiang CW; Benet LZ
Pharmacology; 1984; 28(4):181-7. PubMed ID: 6728896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
